ARIAD Pharma (ARIA) Prices 15.3M Offering at $19.60/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Ariad Pharma (ARIA) Commences Common Stock Offering
January 23, 2013 4:24 PM ESTAriad Pharmaceuticals, Inc. (Nasdaq: ARIA) has commenced an underwritten public offering of shares of its common stock. All of the shares in the offering are to be sold by ARIAD.
J.P. Morgan Securities LLC, Cowen and Company, LLC and Jefferies & Company,... More
